Sera Prognostics Stock Forecast
NASDAQ: SERAHealthcareMedical DevicesUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
SERA analyst consensus
Consensus (4 analysts)
none
Avg. price target
$5.50+172.28%
- Strong buy 0
- Buy 4
- Hold 0
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 4 Wall Street analysts covering Sera Prognostics (2026-10-09), 4 rate the stock a buy or strong buy, 0 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "none". The average 12-month price target is $5.50, with a high estimate of $6.00 and a low estimate of $5.00. The average target implies upside of 172.3% from the current price of $2.02.
The spread between the highest and lowest targets is 20.0%, a relatively narrow range. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for SERA.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 0 | 0% |
| Buy | 4 | 100% |
| Hold | 0 | 0% |
| Sell | 0 | 0% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-09.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $5.00 | +147.52% |
| Average target | $5.50 | +172.28% |
| High target | $6.00 | +197.03% |